BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19715446)

  • 1. Clofarabine: emerging role in leukemias.
    Sampat K; Kantarjian H; Borthakur G
    Expert Opin Investig Drugs; 2009 Oct; 18(10):1559-64. PubMed ID: 19715446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clofarabine as a novel nucleoside analogue approved to treat patients with haematological malignancies: mechanism of action and clinical activity.
    Lech-Maranda E; Korycka A; Robak T
    Mini Rev Med Chem; 2009 Jun; 9(7):805-12. PubMed ID: 19519505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of clofarabine in acute myeloid leukemia.
    Ghanem H; Kantarjian H; Ohanian M; Jabbour E
    Leuk Lymphoma; 2013 Apr; 54(4):688-98. PubMed ID: 22957815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of anti-cancer action and pharmacology of clofarabine.
    Zhenchuk A; Lotfi K; Juliusson G; Albertioni F
    Biochem Pharmacol; 2009 Dec; 78(11):1351-9. PubMed ID: 19576186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clofarabine in the treatment of newly diagnosed acute myeloid leukemia in older adults.
    Tran H; Yang D
    Ann Pharmacother; 2012 Jan; 46(1):89-96. PubMed ID: 22170975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clofarabine.
    Drugs R D; 2004; 5(4):213-7. PubMed ID: 15230627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clofarabine: a new treatment option for patients with acute myeloid leukemia.
    Larson ML; Venugopal P
    Expert Opin Pharmacother; 2009 Jun; 10(8):1353-7. PubMed ID: 19463072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clofarabine in leukemia.
    Ghanem H; Jabbour E; Faderl S; Ghandhi V; Plunkett W; Kantarjian H
    Expert Rev Hematol; 2010 Feb; 3(1):15-22. PubMed ID: 21082931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clofarabine in pediatric acute leukemia: current findings and issues.
    Hijiya N; Barry E; Arceci RJ
    Pediatr Blood Cancer; 2012 Sep; 59(3):417-22. PubMed ID: 22354543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clofarabine: past, present, and future.
    Kantarjian HM; Jeha S; Gandhi V; Wess M; Faderl S
    Leuk Lymphoma; 2007 Oct; 48(10):1922-30. PubMed ID: 17852710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clofarabine for myelodysplastic syndromes.
    Tiu RV; Traina F; Sekeres MA
    Expert Opin Investig Drugs; 2011 Jul; 20(7):1005-14. PubMed ID: 21591997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clofarabine and nelarabine: two new purine nucleoside analogs.
    Gandhi V; Plunkett W
    Curr Opin Oncol; 2006 Nov; 18(6):584-90. PubMed ID: 16988579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia.
    O'Connor D; Sibson K; Caswell M; Connor P; Cummins M; Mitchell C; Motwani J; Taj M; Vora A; Wynn R; Kearns PR
    Br J Haematol; 2011 Aug; 154(4):482-5. PubMed ID: 21689087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel purine nucleoside analogues for hematological malignancies.
    Korycka A; Lech-MaraƄda E; Robak T
    Recent Pat Anticancer Drug Discov; 2008 Jun; 3(2):123-36. PubMed ID: 18537755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nursing considerations for optimal outpatient management of adult patients with leukemia treated with clofarabine.
    Dressel A; Kwari M; McGreal AM
    Clin J Oncol Nurs; 2011 Feb; 15(1):E13-23. PubMed ID: 21278032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European development of clofarabine as treatment for older patients with acute myeloid leukemia considered unsuitable for intensive chemotherapy.
    Burnett AK; Russell NH; Kell J; Dennis M; Milligan D; Paolini S; Yin J; Culligan D; Johnston P; Murphy J; McMullin MF; Hunter A; Das-Gupta E; Clark R; Carr R; Hills RK
    J Clin Oncol; 2010 May; 28(14):2389-95. PubMed ID: 20385984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clofarabine for the treatment of adult acute myeloid leukemia.
    Thomas X; Raffoux E; Elhamri M; Lobe I; Cannas G; Dombret H
    Future Oncol; 2009 Oct; 5(8):1197-210. PubMed ID: 19852733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clofarabine (2-chloro-2'-fluoro-2'-deoxyarabinosyladenine)--biochemical aspects of anticancer activity.
    Majda K; Lubecka K; Kaufman-Szymczyk A; Fabianowska-Majewska K
    Acta Pol Pharm; 2011; 68(4):459-66. PubMed ID: 21796927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clofarabine in the treatment of myelodysplastic syndromes.
    Bryan J; Kantarjian H; Prescott H; Jabbour E
    Expert Opin Investig Drugs; 2014 Feb; 23(2):255-63. PubMed ID: 24410313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of clofarabine activity in childhood and adult acute leukemia: individual tumor response study.
    Styczynski J; Gil L; Derwich K; Wachowiak J; Balwierz W; Badowska W; Krawczuk-Rybak M; Matysiak M; Wieczorek M; Balcerska A; Sonta-Jakimczyk D; Stefaniak J; Kowalczyk J; Urasinski T; Sobol G; Komarnicki M; Wysocki M
    Anticancer Res; 2009 May; 29(5):1643-50. PubMed ID: 19443380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.